NCT04458857 · Interventional trial
A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
Overall registry status Completed
Phase 3
Conditions Migraine
Delaware Valley sites
- Teva Investigational Site 14364 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory